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Abstract
Background: Numerous studies have investigated association of OGG1 Ser326Cys polymorphism with lung cancer
susceptibility; however, the findings are inconsistent. Therefore, we performed a meta-analysis based on 27 publications
encompass 9663 cases and 11348 controls to comprehensively evaluate such associations.
Methods: We searched publications from MEDLINE and EMBASE which were assessing the associations between OGG1
Ser326Cys polymorphism and lung cancer risk. We calculated pooled odds ratio (OR) and 95% confidence interval (CI) by
using either fixed-effects or random-effects model. We used genotype based mRNA expression data from HapMap for SNP
rs1052133 in normal cell lines among 270 subjects with four different ethnicities.
Results: The results showed that individuals carrying the Cys/Cys genotype did not have significantly increased risk for lung
cancer (OR=1.15, 95% CI=0.98–1.36) when compared with the Ser/Ser genotype; similarly, no significant association was
found in recessive, dominant or heterozygous co-dominant model (Ser/Cys vs. Cys/Cys). However, markedly increased risks
were found in relatively large sample size (Ser/Ser vs. Cys/Cys: OR=1.29, 95% CI=1.13–1.48, and recessive model: OR=1.19,
95% CI=1.07–1.32). As to histological types, we found the Cys/Cys was associated with adenocarcinoma risk (Ser/Ser vs.
Cys/Cys: OR=1.32, 95% CI=1.12–1.56; Ser/Cys vs. Cys/Cys: OR=1.19, 95% CI=1.04–1.37, and recessive model OR=1.23,
95% CI=1.08–1.40). No significant difference of OGG1 mRNA expression was found among genotypes between different
ethnicities.
Conclusions: Despite some limitations, this meta-analysis established solid statistical evidence for an association between
the OGG1 Cys/Cys genotype and lung cancer risk, particularly for studies with large sample size and adenocarcinoma, but
this association warrants additional validation in larger and well designed studies.
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Introduction
Cancer is recognized as the leading cause of death in
economically developed countries and the second leading cause
of death in developing countries. It has been estimated that
approximately 12.7 million cancer cases and 7.6 million cancer
deaths have been occurred in 2008. Lung cancer was the most
commonly diagnosed type of cancer as well as the leading cause of
cancer death in males in 2008. Globally, lung cancer accounts for
13% (1.6 million) of the total cases and 18% (1.4 million) of the
deaths [1]. Cigarette smoking is the well known risk factor for lung
cancer, which accounts for 80% of the worldwide lung cancer
burden in males and at least 50% of the burden in females [2].
Tobacco smoke contains multiple carcinogens that are known to
chemically modify of genomic DNA [3] and further lead to genetic
mutations [4].
DNA repair genes play a crucial role in maintaining the stability
and integrity of genomic DNA. In humans, more than 130 genes
are involved in the five major DNA repair pathways, one of which
is base excision repair (BER) pathway [5]. The BER pathway
repairs lesions involving modifications to the DNA bases, including
lesions generated by reactive oxygen species. The specificity of
BER is supported by DNA glycosylases, which have precise
substrate specificities. In mammalian cells there are four major
DNA glycosylases including oxoguanine DNA glycosylase
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35970(OGG1), which primarily recognizes 8-oxodG but also active on
other oxidized purines [6].
The 8-oxoguanine DNA glycosylase (OGG1) gene, located at
chromosome 3p26.2, encodes the enzyme responsible for the
excision of 8-oxoguanine, a mutagenic base byproduct which
occurs as a result of exposure to reactive oxygen species. It
catalyzes the cleavage of the glycosylic bond between the modified
base and the sugar moiety, leaving an abasic apurinic/apyrimi-
dinic site in DNA; the resulting site is then incised, followed by
completing of repair with successive actions of a phosphodiester-
ase, a DNA polymerase and a DNA ligase [7,8]. The OGG1 is
highly polymorphic, and a number of single nucleotide polymor-
phisms (SNPs) have been identified [9–12], with at least 231
reported SNPs in the gene region (http://www.ncbi.nlm.nih.gov/
projects/SNP). However, only few of these reported SNPs are
potentially functional and been studied for their associations with
cancer susceptibility. For OGG1, there are twenty five SNPs that
reportedly change amino acid of the protein but only Ser326Cys
(rs1052133) was extensively investigated for its association with
cancer risk, in particular for lung cancer. Because the results from
these studies were inconsistent [9,13–25], we performed a meta-
analysis of the published reports to further evaluate the association
of OGG1 Ser326Cys SNPs with the risk of lung cancer.
Materials and Methods
Identification and eligibility of relevant studies
Studies included in this meta-analysis were to meet the following
criteria: (a) evaluating the association between OGG1 Ser326Cys
and cancer risk, (b) using a case-control design, (c) providing
sufficient information to estimate odds ratios (ORs) and their 95%
confidence intervals (CIs).
We searched the electronic literature MEDLINE and EMBASE
databases for all relevant articles using the search terms: ‘‘OGG1,
HMMH, MUTM, OGH1 or hOGG1’’, ‘‘variant or variation or
polymorphism’’ and ‘‘lung cancer’’ (last search was updated on
Nov 30, 2011). All eligible studies were retrieved, and their
bibliographies were manually checked for other relevant publica-
tions. Review articles and bibliographies of other relevant studies
identified were hand-searched as well to search for additional
eligible studies. Only published studies with full-text articles in
English were included. If more than one article was published
using the same patient population, only the latest or the largest
study would be used in this meta-analysis. Two authors (Wei-Xun
Duan and Rui-Xi Hua) independently assessed the articles for
compliance with the inclusion criteria, and any disagreement was
resolved by discussions till consensus was reached. In addition,
investigations departure from Hardy-Weinberg equilibrium
(HWE) was excluded from the final analysis.
Data extraction
The following information was collected from each study: first
author’s surname, year of publication, ethnicity of the study
population, cancer types, histological types, source used for controls,
total number of cases and controls, genotype methods and numbers
of cases and controls with the Ser/Ser, Ser/Cys, and Cys/Cys
genotypes for OGG1. For those studies that included subjects of
differentethnicgroups, genotypesdata wereextracted separatelyfor
each of ethnic groups, categorized as Caucasians, Asians, Africans
or Mixed which contained more than one ethnic group.
Genotype and gene expression correlation analysis
The data on OGG1 Ser326Cys (rs1052133C.G) genotype and
transcript (mRNA) expression levels were available by SNPexp
online tool (http://app3.titan.uio.no/biotools/help.php?app=
snpexp) [26]. The genotyping data for OGG1 were derived from
the HapMap phase II release 23 data set consisting of 3.96 million
SNP genotypes from 270 individuals from four populations (CEU:
90 Utah residents with ancestry from northern and western
Europe; CHB: 45 unrelated Han Chinese in Beijing; JPT: 45
unrelated Japanese in Tokyo; YRI: 90 Yoruba in Ibadan, Nigeria)
[27]. The transcript (mRNA) expression data were detected by
using genome-wide expression arrays (47294 transcripts) from
EBV-transformed lymphoblastoid cell lines from the same 270
individuals [28].
Statistical methods
The strength of association between OGG1 Ser326Cys and lung
cancer risk was assessed by calculating ORs with the corresponding
95% CIs. For OGG1 Ser326Cys, the pooled ORs were also
performed for additive (Ser/Ser vs. Cys/Cys and Ser/Cys vs. Cys/
Cys), recessive model (Ser/Ser+Ser/Cys vs. Cys/Cys), and
dominantmodel(Ser/Servs.Ser/Cys+Cys/Cys).The homogeneity
assumption was verified by Chi square-based Q-test. If the studies
were found to be homogeneous (with P.0.10 for the Q test), the
pooled OR estimate of all studies would be calculated by the fixed-
effects model (the Mantel–Haenszel method) [29]. If homogeneity
could not be assumed, a random-effects model (the DerSimonian
and Laird method) would be used [30]. Subgroup analyses were
performed by cancer type, ethnicity, study design and sample size.
To verify the potential publication bias, a standard error of log (OR)
for each study was plotted against its log (OR). Funnel plot
asymmetry was assessed by Egger’s linear regression test [31]. To
assess the effect of individual studies on the overall risk of cancers,
sensitivity analyses were performed by excluding each study
individually and recalculating the ORs and the 95% CIs. The
mRNA expression levels between two strata were assessed by using
Student’s t test. The transcript expression level trends by genotypes
were evaluated by using General linear model. This meta-analysis
was performed by using the software STATA version 11.0 (Stata
Corporation, College Station, TX) and SAS software (version 9.1;
SAS Institute, Cary, NC). All the P values were two-sided, and a
P,0.05 was considered statistically significant.
Results
Study characteristics
As shown in Figure 1, a total of 76 published records were
retrieved, of which 45 were excluded after the abstract was found
to be irrelevant, and one paper was excluded since they published
in Korean [32]. A total of 30 case-control studies met the inclusion
criteria [9,13–25,33] and were included in the meta-analysis
(Table 1). The study by Bonner et al. [33] was excluded in the final
analysis because they used the same samples as a previous article
[34]. The distribution of genotypes for the OGG1 polymorphism in
the controls of all studies was consistent with that expected from
the HWE, except for three studies [23,35,36]. Chang et al. [19]
evaluate the differences in genetic contribution to lung cancer risk
in Latinos and African-American ethnic groups, so this study was
separated in two. Overall, 27 studies with 9663 cases and 11348
controls investigating the OGG1 Ser326Cys SNP were included in
this meta-analysis. The study of Klinchid et al. [20] was included
only in the calculation of the dominant model, because the
genotype distribution was not presented in sufficient detail. Of the
27 studies, sample sizes ranged from 45 to 2155, in which eight
studies focused on non-small cell lung cancer (NSCLC) and
nineteen on mixed lung cancers. There were eleven studies on
Caucasians, twelve studies on Asians, two studies on Africans and
OGG1 Ser326Cys Polymorphisms and Lung Cancer Risk
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confirmed. Controls were mainly matched for sex and age. Of all
the studies, twelve were population-based, fifteen were hospital-
based; three studies with sample size less than 100, nineteen studies
with sample size between 100 to 500, and five studies with sample
size more than 500. For available histological types, six studies
with small cell lung cancer (SCLC), seven with squamous cell
carcinoma (SCC), ten with adenocarcinoma (ADC), one with large
cell carcinoma (LCC), six with NSCLC thus histological type
details not available, and twelve with lung cancer but details not
available that were considered as mixed.
Meta-analysis results
The overall results suggested there was no significant association
between OGG1 Ser326Cys and risk of lung cancer (Ser/Ser vs.
Cys/Cys: OR=1.15, 95% CI=0.98–1.36; Ser/Cys vs. Cys/Cys:
OR=1.09, 95% CI=0.95–1.25), recessive (OR=1.11, 95%
CI=0.97–1.28) or dominant model (OR=1.09, 95% CI=0.98–
Table 1. Characteristics of studies included in the meta-analysis.
Surname Year Country Ethnicity Cancer type Cases/controls
Control
source Genotype method MAF H-W
Khono 1998 Japan Asian Mixed 45/42 PB PCR-SSCP 0.40 0.939
Sugimura 1999 Japan Mixed Mixed 241/197 HB PCR-SSCP 0.41 0.082
Wikman 2000 Germany Caucasian NSCLC 105/105 HB PCR-RFLP 0.22 0.067
Ito 2002 Japan Asian ADC 138/240 HB PCR-CTPP 0.47 0.837
Le 2002 USA Mixed Mixed 298/405 PB PCR-RFLP 0.35 0.350
Sunaga 2002 Japan Asian ADC 198/152 HB PCR-RFLP 0.45 0.126
Lan 2004 China Asian Mixed 118/109 PB SNP500 0.33 0.232
Park 2004 USA Caucasian Mixed 179/350 HB PCR-RFLP 0.15 0.857
Vogel 2004 Denmark Caucasian Mixed 256/269 PB real-time PCR 0.24 0.237
Hung 2005 European Caucasian SCC, ADC 2155/2163 HB TaqMan 0.20 0.215
Khono 2006 Japan Asian ADC 1097/394 HB pyrosequencing 0.45 0.627
Loft 2006 Denmark Caucasian Mixed 251/261 PB real-time PCR 0.24 0.200
Sorensen 2006 Denmark Caucasian Mixed 431/796 PB real-time PCR 0.22 0.258
Matullo 2006 European Caucasian Mixed 116/1094 PB DHPLC 0.22 0.901
De Ruyck 2007 Belgium Caucasian Mixed 110/110 HB PCR-RFLP 0.25 0.176
Hatt 2008 Denmark Caucasian Mixed 158/164 PB TaqMan 0.25 0.536
Karahalil 2008 Turkey Caucasian Mixed 165/250 PB PCR-RFLP 0.33 0.546
Chang 2009 Taiwan Asian Mixed 1096/997 HB MassARRAY 0.60 0.741
Miyaishi 2009 Japan Asian Mixed 108/121 HB PCR-RFLP 0.45 0.271
Okasaka 2009 Japan Asian Mixed 515/1030 PB TaqMan 0.49 0.070
Chang 2009 USA African Mixed 112/296 PB Illumina 0.32 0.691
Chang 2009 USA African Mixed 254/280 PB Illumina 0.15 0.521
Klinchid 2009 Thailand Asian NSCLC 76/75 HB diASA-AMP
Janik 2011 Poland Caucasian NSCLC 88/79 HB PCR-MSSCP 0.15 0.542
Kohno 2011 Japan Asian SCC 377/325 HB pyrosequencing 0.45 0.704
Li 2011 China Asian Mixed 395/443 HB PCR-CTPP 0.62 0.329
Qian 2011 China Asian NSCLC 581/601 HB TaqMan 0.55 0.592
Liang 2005 China Asian SCC, ADC 227/227 HB diASA-AMP 0.61 0.043
Zienolddiny 2006 Norway Caucasian NSCLC 326/386 PB APEX 0.35 0.000
Liu 2010 Taiwan Asian Mixed 358/716 HB PCR-RFLP 0.64 0.004
HB, Hospital based; PB, Population based; SCC, Squamous Cell Carcinoma; NSCLC, non-small cell lung cancer; ADC, Adenocarcinoma; PCR-SSCP, PCR-single strand
conformation polymorphism; PCR-RFLP, PCR-restriction fragment length polymorphisms; PCR-CTPP, polymerase chain reaction with confronting two-pair primers;
diASA-AMP, di-allele-specific amplification with artificially modified primers; DHPLC, denaturing high performance liquid chromatography.
doi:10.1371/journal.pone.0035970.t001
Figure 1. Flow chart of Included Studies.
doi:10.1371/journal.pone.0035970.g001
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statistically significant association was found for studies with large
sample size (Ser/Ser vs. Cys/Cys: OR=1.29, 95% CI=1.13–
1.48; Ser/Ser+Ser/Cys vs. Cys/Cys: OR=1.19, 95% CI=1.07–
1.32), and a relative small sample size (,100) for dominant model
(OR=1.79, 95% CI=1.08–2.98) which just included three
studies. Further stratification by cancer type, ethnicity, and source
of controls all yielded no statistically significant estimates. In the
histological type subgroup analysis with more details, the OGG1
Ser326Cys allele was significantly associated with risk of ADC
(Ser/Ser vs. Cys/Cys: OR=1.32, 95% CI=1.12–1.56; Ser/Cys
vs. Cys/Cys: OR=1.19, 95% CI=1.04–1.37) and recessive
model (OR=1.23, 95% CI=1.08–1.40), but not with cancers of
the SCC, SCLC and LCC (Table 3, Figure 2).
The mRNA expression by genotypes
The mRNA expression level of OGG1 by the genotypes of four
ethnicities is shown in Table 4. We did not find any mRNA
expression difference between different genotypes among the four
different ethnicities. Thus, mRNA expression level was a little
higher though no significant difference for rs1052133G variant
allele was found in Asian populations. No trend of transcript
expression levels by genotypes was found for OGG1.
Table 2. Meta-analysis of the association between OGG1 Ser326Cys polymorphism and lung cancer risk.
Variables
No. of
studies Homozygous Phet
a Heterozygous Phet
a Recessive Phet
a Dominant Phet
a
Ser/Ser vs. Cys/Cys Ser/Cys vs. Cys/Cys
(Ser/Ser+Ser/Cys)
vs. Cys/Cys
Ser/Ser vs. (Ser/
Cys+Cys/Cys)
All 27 1.15 (0.98–1.36) 0.001 1.09 (0.95–1.25) 0.010 1.11 (0.97–1.28) 0.002 1.09 (0.98–1.21) ,0.001
Cancer type
NSCLC 8 1.29 (0.99–1.69) 0.118 1.14 (0.85–1.55) 0.054 1.18 (0.90–1.54) 0.029 1.20 (0.99–1.45) 0.125
Mixed 19 1.09 (0.89–1.34) 0.002 1.08 (0.92–1.26) 0.016 1.09 (0.92–1.29) 0.006 1.05 (0.93–1.19) 0.001
Ethnicity
Caucasian 11 1.12 (0.78–1.62) 0.014 1.08 (0.79–1.47) 0.107 1.11 (0.79–1.55) 0.028 1.05 (0.88–1.25) 0.001
Asian 12 1.15 (0.92–1.43) 0.004 1.04 (0.89–1.22) 0.030 1.07 (0.91–1.27) 0.007 1.15 (0.98–1.35) 0.018
African 2 1.00 (0.54–1.84) 0.802 0.98 (0.53–1.82) 0.423 1.01 (0.56–1.83) 0.653 1.12 (0.82–1.52) 0.279
Mixed 2 1.48 (0.96–2.27) 0.224 1.73 (1.23–2.43) 0.368 1.61 (1.14–2.28) 0.284 1.01 (0.79–1.29) 0.334
Source of controls
Population 12 1.15 (0.94–1.40) 0.335 1.09 (0.88–1.36) 0.221 1.14 (0.94–1.38) 0.273 1.08 (0.97–1.19) 0.617
Hospital 15 1.20 (0.94–1.54) ,0.001 1.11 (0.92–1.33) 0.005 1.13 (0.93–1.38) ,0.001 1.10 (0.93–1.31) ,0.001
Sample size
,100 3 4.46 (0.29–68.84) 0.021 3.88 (0.41–36.47) 0.059 4.33 (0.33–57.22) 0.024 1.79 (1.08–2.98) 0.302
100–500 19 1.05 (0.83–1.34) 0.002 1.01 (0.82–1.25) 0.010 1.04 (0.84–1.29) 0.002 1.04 (0.91–1.19) 0.002
.500 5 1.29 (1.13–1.48) 0.920 1.05 (0.81–1.37) 0.842 1.19 (1.07–1.32) 0.953 1.12 (0.96–1.31) 0.046
aP value of the Q-test for heterogeneity test.
doi:10.1371/journal.pone.0035970.t002
Table 3. Meta-analysis of the association between OGG1 Ser326Cys polymorphism and lung cancer with definite histological
types.
Variables
No. of
studies Homozygous Phet
a Heterozygous Phet
a Recessive Phet
a Dominant Phet
a
Ser/Ser vs. Cys/Cys Ser/Cys vs. Cys/Cys
(Ser/Ser+Ser/Cys) vs.
Cys/Cys
Ser/Ser vs. (Ser/
Cys+Cys/Cys)
Histological types
SCLC 6 0.90 (0.57–1.42) 0.149 0.98 (0.67–1.44) 0.696 0.97 (0.68–1.39) 0.357 1.07 (0.67–1.72) 0.014
SCC 7 1.14 (0.91–1.42) 0.306 1.16 (0.96–1.41) 0.163 1.14 (0.95–1.38) 0.143 1.04 (0.84–1.28) 0.101
ADC 10 1.32 (1.12–1.56) 0.233 1.19 (1.04–1.37) 0.186 1.23 (1.08–1.40) 0.248 1.13 (0.93–1.38) 0.014
LCC 1 3.19 (0.63–16.03) - 2.18 (0.41–11.69) - 2.85 (0.58–14.03) - 1.61 (0.76–3.42) -
NSCLC 6 1.34 (1.03–1.75) 0.065 1.11 (0.89–1.39) 0.155 1.18 (0.95–1.46) 0.086 1.25 (0.97–1.61) 0.147
Mixed 12 1.24 (1.02–1.49) 0.364 1.20 (1.00–1.43) 0.320 1.24 (1.05–1.46) 0.307 1.08 (0.96–1.22) 0.371
SCLC, Small cell lung cancer; SCC, Squamous Cell Carcinoma; ADC, Adenocarcinoma; LCC, Large cell carcinoma; NSCLC, non-small cell lung cancer.
aP value of the Q-test for heterogeneity test.
doi:10.1371/journal.pone.0035970.t003
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No publication bias was detected for OGG1 Ser326Cys (the
Egger’s test, Ser/Ser vs. Cys/Cys: P=0.944, Ser/Cys vs. Cys/
Cys: P=0.987, recessive model: P=0.892, dominant model:
P=0.217).
Discussion
It is well recognized that individual susceptibility to cancer
varies, even after exposure to the same environment. Therefore, it
has been suggested that genetic variation, such as SNPs of genes is
involved in carcinogenesis. We conducted a meta-analysis of
published studies to evaluate the association between the OGG1
Ser326Cys polymorphism and lung cancer risk because no such
up-to-date meta-analysis including histological types has been
published to date. We found no statistical evidence of an overall
effect of the Ser326Cys polymorphism on lung cancer risk in either
recessive or dominant effect models. Compared with the Ser/Ser
genotype, the variant Cys/Cys genotype was not significantly
associated with overall lung cancer risk in all subjects from 27
eligible studies included in the analysis. In a previous meta-analysis
with 17 studies consist of 6375 cases and 6406 controls,
Figure 2. ORs of lung cancer with definite histological types associated with the OGG1 Ser/Ser genotype compared with the Cys/Cys
genotype. For each study, the estimates of OR and its 95% CI are plotted with a box and a horizontal line. e, pooled ORs and its 95% CIs.
doi:10.1371/journal.pone.0035970.g002
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dominant model, and lung cancer risk associated with the OGG1
Cys/Cys genotype was significantly increased in population-based
studies [9]. However, these were not found in ours, may be
attributed to a larger sample size.
Previous studies demonstrated that genetic variation in OGG1
affects cancer susceptibility; the frequency of the OGG1 326Cys
allele was found to be significantly higher in patients when
compared with controls [22,24,25,37,38]; however, this associa-
tion was not replicated by other studies [9,13–17]. Overall, we did
not found that individuals carrying the Cys/Cys genotype had
significantly increased risk of lung cancer when compared with the
Ser/Ser genotype, no significant association with lung cancer risk
was found in dominant model, recessive model and heterozygous
co-dominant model (Ser/Cys vs. Cys/Cys). However, markedly
increased risks were found in relatively large sample size, and this
hinted us that in the future studies, only the studies with large
sample size would be reliable. In the histological type subgroup
analysis, the OGG1 Ser326Cys allele was significantly associated
with risk of ADC, but not with cancers of the SCC, SCLC and
LCC. These may be attributed to the tumor specificity.
Mambo et al. [39] analyzed the expression of hOGG1 mRNA in
18 lung cancer and three normal cell lines and found hOGG1 was
over expressed in most cell lines, 2/18 (11.1%) showed a lower
hOGG1 mRNA and protein expression (,80% decrease) relative to
normal cell lines, indicating 8-Hydroxyguanine repair defects in
certain lung cancers. When we compared the mRNA expression
levels of OGG1 Ser326Cys by the genotypes of four different
ethnicities, no difference or trend was found. Lung cancer is
known to be a complex and multifactorial disease, gene-gene and
gene-environment interactions both contribute greatly to the
occurrence of this disease, a single nucleotide variation may be
insufficient to alter the OGG1 mRNA expression especially the
ones in the coding regions which just lead to amino acid alteration.
Though we included the latest data, there are several limitations
in this meta-analysis must also be considered. First, lack of the
original data of lung cancer histological types limited our further
evaluation of histological types and genotypes interactions.
Second, lack of the original data limited our further evaluation
of potential gene-gene and gene-environment interactions. Third,
lack of information on disease status, genotypes, and well-
documented smoking status may also influence the results. Fourth,
most of the studies except for five [17,21,22,40,41] had a relatively
small sample sizes (,500 cases and controls). Finally, the studies
included in the analysis have used more than ten different
genotyping methods that had different quality control issues.
In conclusion, this meta-analysis found that the OGG1 326Cys/
Cys genotype was not associated with significantly increased risk of
lung cancer. However, given the relatively limited lung cancer
histological types and sample size, Cys/Cys was associated with
adenocarcinoma risk. However, further studies are warranted to
validate the association between the OGG1 Ser326Cys polymor-
phism and lung cancer risk with larger sample size and more
detailed histological types.
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b Ptrend
c
CHB CC 11 7.8460.20 0.267
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GG 11 7.9660.29 0.264
CG/GG 34 7.9560.26 0.234
JPT
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GG 10 7.8160.16 0.102
CG/GG 36 7.8060.17 0.057
CEU
d CC 55 7.8760.31 0.283
CG 26 7.8960.28 0.781
GG 6 7.6360.18 0.082
CG/GG 32 7.8460.28 0.689
YRI
d CC 65 7.8060.23 0.753
CG 20 7.7760.20 0.568
GG 3 7.8360.20 0.869
CG/GG 23 7.7860.19 0.637
Asian
d CC 19 7.7760.21 0.106
CG 49 7.8660.23 0.117
GG 21 7.8960.24 0.102
CG/GG 70 7.8760.23 0.083
All
d CC 139 7.8260.26 0.620
CG 95 7.8560.24 0.420
GG 30 7.8360.24 0.883
CG/GG 125 7.8560.24 0.468
aGenotyping data and mRNA expression levels for OGG1 Ser326Cys by
genotypes obtained from the HapMap phase II release 23 data from EBV-
transformed lymphoblastoid cell lines from 270 individuals. CHB: 45 unrelated
Han Chinese in Beijing; JPT: 45 unrelated Japanese in Tokyo; CEU: 90 Utah
residents with ancestry from northern and western Europe; YRI: 90 Yoruba in
Ibadan, Nigeria.
bTwo-side Student’s t test within the stratum.
cP values for the trend test of OGG1 mRNA expression among 3 genotypes for
each SNP from a general linear model.
dThere were missing data because genotyping data were not available.
doi:10.1371/journal.pone.0035970.t004
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